Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoji Ishizu
Successful Treatment of Hepatocellular Carcinoma With Regorafenib After Sorafenib-Induced Hypersensitivity
Internal Medicine
Internal Medicine
Medicine
Related publications
Pcn17 - Indirect Treatment Comparisons of Nivolumab Versus Regorafenib, Cabozantinib and Best Supportive Care After Treatment With Sorafenib for Hepatocellular Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Sorafenib in Hepatocellular Carcinoma
Clinical Medicine. Therapeutics
Sorafenib and Regorafenib in HBV- Or HCV-positive Hepatocellular Carcinoma Patients: Analysis of RESORCE and SHARP Trials
Digestive and Liver Disease
Hepatology
Gastroenterology
A Case of Hepatocellular Carcinoma With Disappearance of Lymph Node Metastasis After Sorafenib Administration
Acta Hepatologica Japonica
Hepatology
Pcn151 - Cost-Effectiveness Analysis of Regorafenib in the Treatment of Patients With Hepatocelullar Carcinoma Previously Treated With Sorafenib in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma
Journal of Liver Research, Disorders & Therapy
Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Postsorafenib Systemic Treatments for Hepatocellular Carcinoma: Questions and Opportunities After the Regorafenib Trial
Future Oncology
Medicine
Cancer Research
Oncology
